Bangkok Biotech China Coronavirus Covid-19 education Medicine Thailand United States University Vaccine
BANGKOK (REUTERS) – Two coronavirus vaccines administered using a nasal spray being developed in Thailand are due to start human trials by the end of this year, after promising results in trials involving mice, a government official said on Wednesday (Aug 11). Developed by the National Centre for Genetic Engineering and Biotechnology, the vaccines are based on the adenovirus and influenza, deputy government spokesman Ratchada Thanadirek said. After conducting trials in mice, the first phase of human trials should start by the end of this year, pending approval from the food and drug regulator, she said. The trials will also…
News Timeline:
Track the development of this news story across the Internet.